These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 31332071)

  • 1. A Novel, Broad-Spectrum Antimicrobial Combination for the Treatment of Pseudomonas aeruginosa Corneal Infections.
    Chojnacki M; Philbrick A; Scherzi T; Pecora N; Dunman PM; Wozniak RAF
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a Broad-Spectrum Antimicrobial Combination for the Treatment of Staphylococcus aureus and Pseudomonas aeruginosa Corneal Infections.
    Chojnacki M; Philbrick A; Wucher B; Reed JN; Tomaras A; Dunman PM; Wozniak RAF
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30420484
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of antimicrobial peptides in ophthalmology: an experimental study in corneal preservation and the management of bacterial keratitis.
    Mannis MJ
    Trans Am Ophthalmol Soc; 2002; 100():243-71. PubMed ID: 12545697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of mupirocin and polymyxin B in experimental Staphylococcus aureus, Pseudomonas aeruginosa, and Serratia marcescens keratitis.
    Moreau JM; Conerly LL; Hume EB; Dajcs JJ; Girgis DO; Cannon BM; Thibodeaux BA; Stroman DW; O'Callaghan RJ
    Cornea; 2002 Nov; 21(8):807-11. PubMed ID: 12410042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial Activity of a Triple Antibiotic Combination Toward Ocular Pseudomonas aeruginosa Clinical Isolates.
    Mei JA; Johnson W; Kinn B; Laskey E; Nolin L; Bhamare P; Stalker C; Dunman PM; Wozniak RAF
    Transl Vis Sci Technol; 2022 May; 11(5):26. PubMed ID: 35612831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy of topical moxifloxacin versus ciprofloxacin and vancomycin in the treatment of P. aeruginosa and ciprofloxacin-resistant MRSA keratitis in rabbits.
    Aliprandis E; Ciralsky J; Lai H; Herling I; Katz HR
    Cornea; 2005 Mar; 24(2):201-5. PubMed ID: 15725889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of virulence factors, antimicrobial resistance patterns and biofilm formation of Pseudomonas aeruginosa and Staphylococcus spp. strains isolated from corneal infection.
    Heidari H; Hadadi M; Sedigh Ebrahim-Saraie H; Mirzaei A; Taji A; Hosseini SR; Motamedifar M
    J Fr Ophtalmol; 2018 Nov; 41(9):823-829. PubMed ID: 30292385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of topical chlorhexidine, ciprofloxacin, and fortified tobramycin/cefazolin in rabbit models of Staphylococcus and Pseudomonas keratitis.
    Bu P; Riske PS; Zaya NE; Carey R; Bouchard CS
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):213-20. PubMed ID: 17593004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bactericidal effect of photo-activated riboflavin using UVA.
    Wiwanitkit V
    Graefes Arch Clin Exp Ophthalmol; 2010 May; 248(5):755; author reply 757-8. PubMed ID: 20091179
    [No Abstract]   [Full Text] [Related]  

  • 10. A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa.
    Rhee MK; Kowalski RP; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ
    Am J Ophthalmol; 2004 Aug; 138(2):226-30. PubMed ID: 15289131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-chlorotaurine and its analogues N,N-dichloro-2,2-dimethyltaurine and N-monochloro-2,2-dimethyltaurine are safe and effective bactericidal agents in ex vivo corneal infection models.
    Teuchner B; Eitzinger C; Lutz M; Hager T; Schmid E; Bechrakis NE; Zuck M; Jekle A; Debabov D; Anderson M; Nagl M
    Acta Ophthalmol; 2012 Dec; 90(8):e632-7. PubMed ID: 22971221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness of two ciprofloxacin formulations for experimental Pseudomonas and Staphylococcus keratitis.
    Engel LS; Callegan MC; Hill JM; Folkens AT; Shimomura Y; O'Callaghan RJ
    Jpn J Ophthalmol; 1996; 40(2):212-9. PubMed ID: 8876389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a Novel Ophthalmic Antimicrobial Drug Combination Toward a Large Panel of Staphylococcus aureus Clinical Ocular Isolates From Around the World.
    Laskey E; Chen Y; Sohn MB; Gruber E; Chojnacki M; Wozniak RAF
    Cornea; 2020 Oct; 39(10):1278-1284. PubMed ID: 32639313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of a Novel Antibiotic Drug Combination Toward Multidrug-Resistant Ocular Pathogens.
    Gowtham L; Wozniak RAF; Dunman PM; Sheba E; Garg P; Joseph J
    Cornea; 2024 Aug; 43(8):1044-1048. PubMed ID: 38537125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Pseudomonas keratitis in humans.
    Hessburg PC
    Am J Ophthalmol; 1966 May; 61(5 Pt 1):896-903. PubMed ID: 16874993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo challenging of polymyxins and levofloxacin eye drop against multidrug-resistant Pseudomonas aeruginosa keratitis.
    Tajima K; Miyake T; Koike N; Hattori T; Kumakura S; Yamaguchi T; Matsumoto T; Fujita K; Kuroda M; Ito N; Goto H
    J Infect Chemother; 2014 Jun; 20(6):343-9. PubMed ID: 24726376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designed Host Defense Peptides for the Treatment of Bacterial Keratitis.
    Clemens LE; Jaynes J; Lim E; Kolar SS; Reins RY; Baidouri H; Hanlon S; McDermott AM; Woodburn KW
    Invest Ophthalmol Vis Sci; 2017 Dec; 58(14):6273-6281. PubMed ID: 29242901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antibiotic resistance profiles of Pseudomonas aeruginosa in the Asia Cornea Society Infectious Keratitis Study.
    Khor WB; Lakshminarayanan R; Periayah MH; Prajna VN; Garg P; Sharma N; Mehta JS; Young A; Goseyarakwong P; Puangsricharern V; Tan AL; Beuerman RW; Tan DT;
    Int Ophthalmol; 2024 Aug; 44(1):361. PubMed ID: 39215853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishing a Porcine Ex Vivo Cornea Model for Studying Drug Treatments against Bacterial Keratitis.
    Okurowska K; Roy S; Thokala P; Partridge L; Garg P; MacNeil S; Monk PN; Karunakaran E
    J Vis Exp; 2020 May; (159):. PubMed ID: 32478743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical ciprofloxacin versus topical fortified antibiotics in rabbit models of Staphylococcus and Pseudomonas keratitis.
    Lauffenburger MD; Cohen KL
    Cornea; 1993 Nov; 12(6):517-21. PubMed ID: 8261784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.